# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment...
Rapid Micro Biosystems (NASDAQ:RPID) FY2025 Revenue expected to be more than $32.00M vs $32.60M Est
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate...
Lake Street analyst Thomas Flaten initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with a Buy rating and announces...